Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

Article activity feed

1. Version published to 10.1371/journal.ppat.1008817

   Sep 24, 2020
2. 

   ScreenIT

   Jun 9, 2020

   SciScore for 10.1101/2020.06.02.20120345: (What is this?)

   Please note, not all rigor criteria are appropriate for all manuscripts.

   Table 1: Rigor

   Institutional Review Board Statement	not detected.
   Randomization	not detected.
   Blinding	not detected.
   Power Analysis	not detected.
   Sex as a biological variable	not detected.
   Cell Line Authentication	not detected.

   Table 2: Resources

   Antibodies
   Sentences	Resources
   Lateral Flow Immunoassays (LFIA): We tested seven point-of-care colloidal-gold-based LFIAs detecting IgG and IgM antibodies against SARS-CoV-2.	colloidal-gold-based LFIAs detecting IgG suggested: None SARS-CoV-2 suggested: None
   Experimental Models: Cell Lines
   Sentences	Resources
   This protein was expressed in 500 mL HEK-293F cells (Invitrogen) at a density of 1.5 million cells/mL.	HEK-293F suggested: RRID:CVCL_6642)
   Software and Algorithms
   Sentences	Resources
   Statistic…

   SciScore for 10.1101/2020.06.02.20120345: (What is this?)

   Please note, not all rigor criteria are appropriate for all manuscripts.

   Table 1: Rigor

   Institutional Review Board Statement	not detected.
   Randomization	not detected.
   Blinding	not detected.
   Power Analysis	not detected.
   Sex as a biological variable	not detected.
   Cell Line Authentication	not detected.

   Table 2: Resources

   Antibodies
   Sentences	Resources
   Lateral Flow Immunoassays (LFIA): We tested seven point-of-care colloidal-gold-based LFIAs detecting IgG and IgM antibodies against SARS-CoV-2.	colloidal-gold-based LFIAs detecting IgG suggested: None SARS-CoV-2 suggested: None
   Experimental Models: Cell Lines
   Sentences	Resources
   This protein was expressed in 500 mL HEK-293F cells (Invitrogen) at a density of 1.5 million cells/mL.	HEK-293F suggested: RRID:CVCL_6642)
   Software and Algorithms
   Sentences	Resources
   Statistical Analysis: Expected binomial exact 95% confidence intervals were calculated on Prism 8.0 using Wilson/Brown statistical analysis.	Prism suggested: (PRISM, RRID:SCR_005375)

   ---

   Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

   ---

   Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

   ---

   Results from TrialIdentifier: No clinical trial numbers were referenced.

   ---

   Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

   ---

   Results from JetFighter: We did not find any issues relating to colormaps.

   ---

   Results from rtransparent:

   • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
   • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
   • No protocol registration statement was detected.

   ---

   Read the original source
3. 

   Version published to 10.1101/2020.06.02.20120345v1 on medRxiv

   Jun 4, 2020